Delray Medical Center made the top 10 for highest patient enrollment numbers out of the 150 sites that participated in the global Study of Neuroprotective Activity of Progesterone in Severe Traumatic Brain Injuries (SyNAPSe) trial. Over a two-year period, Delray Medical Center enrolled about a dozen patients throughout Palm Beach County.
The SyNAPSe trial, led by Dr. Lloyd Zucker, chief of neurosurgery at Delray Medical Center, evaluated the effectiveness of treating severe traumatic brain injury (TBI) patients with the reproductive progesterone hormone. Dosing began within eight hours after injury and continued for 120 hours. Patient outcomes were assessed six months later based on the Glasgow Outcome Scale.
